DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical’s TRYTON Side Branch Stent™ System was discussed as an important new therapeutic option for patients with bifurcation disease last week at the annual European Bifurcation Club (EBC) meeting in Lisbon, Portugal, where approximately 150 international interventional cardiologists gathered to share best practices for challenging bifurcation cases.
“Tryton is pleased to work with these visionaries as we continue a leadership role in pioneering an innovative solution to this long-standing challenge in interventional cardiology.” Patrick W. Serruys, M.D., Ph.D., of Erasmus Medical Center in Rotterdam, the Netherlands, presented an overview of the Tryton stent system, highlighting results from a number of studies of the device and the growing body of clinical evidence supporting the use of the Tryton stent system.
“Tryton is pleased to work with these visionaries as we continue a leadership role in pioneering an innovative solution to this long-standing challenge in interventional cardiology.” Patrick W. Serruys, M.D., Ph.D., of Erasmus Medical Center in Rotterdam, the Netherlands, presented an overview of the Tryton stent system, highlighting results from a number of studies of the device and the growing body of clinical evidence supporting the use of the Tryton stent system.
